ClearSign Technologies (CLIR) 10-K 26 Feb 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Feb. 26, 2015	Jun. 30, 2014
Document Information [Line Items]
Entity Registrant Name	CLEARSIGN COMBUSTION CORP
Entity Central Index Key	1434524
Current Fiscal Year End Date	-19
Entity Filer Category	Smaller Reporting Company
Trading Symbol	CLIR
Entity Common Stock, Shares Outstanding		12,671,476
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$70,900,000

Balance_Sheets

Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current Assets:
Cash and cash equivalents	$1,845,000	$2,688,000
Prepaid expenses	109,000	118,000
Total current assets	1,954,000	2,806,000
Fixed assets, net	263,000	427,000
Patents and other intangible assets, net	2,372,000	1,459,000
Other assets	10,000	10,000
Total Assets	4,599,000	4,702,000
Current Liabilities:
Accounts payable	253,000	297,000
Accrued compensation and taxes	982,000	586,000
Total current liabilities	1,235,000	883,000
Long Term Liabilities:
Long-term accrued compensation and taxes	372,000	0
Deferred rent	33,000	31,000
Total liabilities	1,640,000	914,000
Commitments
Stockholders' Equity:
Preferred stock, $0.0001 par value, zero shares issued and outstanding	0	0
Common stock, $0.0001 par value, 9,681,476 and 8,810,674 shares issued and outstanding at December 31, 2014 and 2013, respectively	1,000	1,000
Additional paid-in capital	24,218,000	17,751,000
Accumulated deficit	-21,260,000	-13,964,000
Total stockholders' equity	2,959,000	3,788,000
Total Liabilities and Stockholders' Equity	$4,599,000	$4,702,000

Balance_Sheets_Parenthetical

Balance Sheets [Parenthetical] (USD $)	Dec. 31, 2014	Dec. 31, 2013
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares issued	9,681,476	8,810,674
Common stock, shares outstanding	9,681,476	8,810,674

Statements_of_Operations

Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Co-development revenue	$0	$93,000
Cost of co-development revenue	0	88,000
Gross profit	0	5,000
Operating expenses:
Research and development	2,217,000	1,851,000
General and administrative	5,084,000	3,450,000
Total operating expenses	7,301,000	5,301,000
Loss from operations	-7,301,000	-5,296,000
Other income:
Interest income	5,000	11,000
Net Loss	($7,296,000)	($5,285,000)
Net Loss per share - basic and fully diluted (in dollars per share)	($0.77)	($0.60)
Weighted average number of shares outstanding - basic and fully diluted (in shares)	9,507,185	8,795,810

Statement_of_Stockholders_Equi

Statement of Stockholders' Equity (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balances at Dec. 31, 2012	$8,636,000	$1,000	$17,314,000	($8,679,000)
Balances (in shares) at Dec. 31, 2012		8,752,015
Shares issued for services	150,000	0	150,000	0
Shares issued for services (in shares)		30,000
Shares issued for services one	102,000	0	102,000	0
Shares issued for services one (in shares)		11,250
Shares issued upon exercise of warrant ($2.20 per share)	39,000	0	39,000	0
Shares issued upon exercise of warrant ($2.20 per share) (in shares)		17,409
Share based compensation	146,000	0	146,000	0
Share based compensation (in shares)		0
Net loss	-5,285,000	0	0	-5,285,000
Balances at Dec. 31, 2013	3,788,000	1,000	17,751,000	-13,964,000
Balances (in shares) at Dec. 31, 2013		8,810,674
Shares issued for services	222,000	0	222,000	0
Shares issued for services (in shares)		21,625
Shares issued in registered direct offering ($8.00 per share)	6,500,000	0	6,500,000	0
Shares issued in registered direct offering ($8.00 per share) (in shares)		812,500
Issuance costs of registered direct offering	-812,000	0	-812,000	0
Share based payments of warrants	92,000	0	92,000	0
Shares issued upon exercise of options ($2.20 per share)	35,000	0	35,000	0
Shares issued upon exercise of options ($2.20 per share) (in shares)		23,337
Shares issued upon exercise of options ($4.88 per share)	65,000	0	65,000	0
Shares issued upon exercise of options ($4.88 per share) (in shares)		13,340
Share based compensation	365,000	0	365,000	0
Share based compensation (in shares)		0
Net loss	-7,296,000	0	0	-7,296,000
Balances at Dec. 31, 2014	$2,959,000	$1,000	$24,218,000	($21,260,000)
Balances (in shares) at Dec. 31, 2014		9,681,476

Statement_of_Stockholders_Equi1

Statement of Stockholders' Equity [Parenthetical] (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Common stock for services per share issue	$10.26	$5
Common stock for services per share issue one		$9.12
Stock issued in registered direct offering price per share	$8
Shares issued upon exercise of warrant		$2.20
Stock issued during period par value exercise of options	$2.20
Stock issued during period par value exercise of options one	$4.88

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net loss	($7,296,000)	($5,285,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock issued for services	222,000	252,000
Share based payments	365,000	146,000
Depreciation and Amortization	243,000	209,000
Abandonment of capitalized patents	262,000	4,000
Deferred rent	2,000	-4,000
Change in operating assets and liabilities:
Prepaid expenses	9,000	-58,000
Accounts payable	-44,000	21,000
Accrued compensation	768,000	418,000
Net cash used in operating activities	-5,469,000	-4,297,000
Cash flows from investing activities:
Acquisition of fixed assets	-78,000	-236,000
Disbursements for patents and other intangible assets	-1,176,000	-845,000
Net cash used in investing activities	-1,254,000	-1,081,000
Cash flows from financing activities:
Proceeds from issuance of common stock for cash, net of offering costs	5,780,000	39,000
Proceeds from exercise of stock options	100,000	0
Net cash provided by financing activities	5,880,000	39,000
Net decrease in cash and cash equivalents	-843,000	-5,339,000
Cash and cash equivalents, beginning of year	2,688,000	8,027,000
Cash and cash equivalents, end of year	$1,845,000	$2,688,000

Supplemental_disclosure_of_non

Supplemental disclosure of non-cash operating and financing activities: (USD $)	12 Months Ended
	Dec. 31, 2014
Warrants Authorized For Issuance To Acquire Common Stock Value	$92,000
Warrants Authorized For Issuance To Acquire Common Stock Shares Number	20,313
July 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	10,000
Shares Issued, Price Per Share	$2.20
Sale of Stock, Price Per Share	$8.93
Stock Issued During Period, Shares, Other	7,537

Organization_and_Description_o

Organization and Description of Business	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Organization, Consolidation, Basis Of Presentation, Business Description and Accounting Policies [Text Block]	Note 1 – Organization and Description of Business
	ClearSign Combustion Corporation (ClearSign or the Company) designs, develops, and markets technologies for the purpose of improving key performance characteristics of combustion systems, including emission and operational performance, energy efficiency and overall cost-effectiveness. The Company’s primary technologies include its Duplex™ technology, which achieves very low emissions without the need of external flue gas recirculation, selective catalytic reduction, or higher excess air operation, and its Electrodynamic Combustion Control™ or ECC™ technology, which introduces a computer-controlled electric field into the combustion region which may better control gas-phase chemical reactions and improve system performance and cost-effectiveness. The Company is located in Seattle, Washington and was incorporated in the state of Washington in 2008.
	The Company has generated limited revenues from operations to date to meet its operating expenses, and has historically financed its operations primarily through issuances of equity securities. The Company has incurred losses since its inception totaling $21,260,000 and expects to experience operating losses and negative cash flow for the foreseeable future. Management believes that the successful growth and operation of the Company’s business is dependent upon its ability to obtain adequate sources of funding through co-development agreements, strategic partnering agreements, or equity or debt financing to adequately support research and development efforts, protect intellectual property, form relationships with strategic partners, and provide for working capital and general corporate purposes. There can be no assurance that the Company will be successful in achieving its long-term plans as set forth above, or that such plans, if consummated, will enable the Company to obtain profitable operations or continue in the long-term as a going concern.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 2 – Summary of Significant Accounting Policies
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Revenue Recognition
	The Company recognizes revenue on co-development agreements using the percentage of completion method. Under this method, the completion percentage is determined by dividing costs incurred to date by total estimated project costs. Since these projects will require technological development to complete, which by its nature is difficult to predict, the actual cost required to complete contracted work may vary from estimates. Estimated project costs are revised regularly which can alter the reported level of project profitability. Any estimated project losses are recognized in the current reporting period. Customer billings are recorded when cash receipts are probable and in accordance with the underlying co-development contract. If billings exceed recognized revenue, the difference is recorded as a current liability, while any recognized revenues exceeding billings are recorded as a current asset. Recognized revenues are subject to revisions as the contract progresses to completion and actual revenue and cost become certain. Revisions in revenue estimates are reflected in the period in which the facts that give rise to the revision become known. There were no revenues for the year ended December 31, 2014 and $93,000 for the year ended December 31, 2013.
	Cost of Revenue
	Cost of co-development revenue includes both direct and allocated indirect costs of completing the scope of work of co-development agreements. Direct costs include labor, materials and other costs incurred directly in fulfilling co-development agreements. Indirect costs include labor, rent, depreciation and other costs associated with operating the Company. Due to the nature of the work involved, the cost of co-development projects may fluctuate substantially from period to period.
	Cash and Cash Equivalents
	Highly liquid investments purchased with an original maturity of three months or less are considered cash equivalents. Cash is maintained with a commercial bank where accounts are generally guaranteed by the Federal Deposit Insurance Corporation up to $250,000. The Company’s deposits may at times exceed this limit. The Company has not experienced losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.
	Fixed Assets
	Fixed assets are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Leasehold improvements are depreciated over the life of the lease or their useful life, whichever is shorter. All other fixed assets are depreciated over two to four years. Maintenance and repairs are expensed as incurred.
	Patents and Trademarks
	Patents and trademarks are recorded at cost. Amortization is computed using the straight-line method over the estimated useful lives of the assets once they are awarded.
	Impairment of Long-Lived Assets
	The Company tests long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected to result from the use and eventual disposition of the assets. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal.
	Fair Value of Financial Instruments
	Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
	The Company's financial instruments primarily consist of cash and cash equivalents, accounts payable and accrued expenses. As of the balance sheet dates, the estimated fair values of the financial instruments were not materially different from their carrying values as presented on the balance sheets. This is primarily attributed to the short maturities of these instruments. The Company did not identify any other non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value.
	Research and Development
	The cost of research and development is expensed as incurred. Research and development costs consist of salaries, benefits, share based compensation, consulting fees, rent, utilities, depreciation, and consumables. In 2014, the Company received $110,000 to partially fund certain laboratory research activities. Since these funds were provided without expectation of reciprocation except notification of the research results, the Company recognized these funds when they were received and recorded them as an offset to research and development expense.
	Deferred Rent
	Operating lease agreements which contain provisions for future rent increases or periods in which rent payments are reduced or abated are recorded in monthly rent expense in the amount of the total payments over the lease term divided by the number of months of the lease term. The difference between rent expense recorded and the amount paid is credited or charged to deferred rent which is reflected on the accompanying balance sheets.
	Income Taxes
	The Company accounts for income taxes using an asset and liability approach which allows for the recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. Tax benefits from an uncertain tax position are recognized only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate resolution.
	Stock-Based Compensation
	The costs of all employee stock options, as well as other equity-based compensation arrangements, are reflected in the financial statements based on the estimated fair value of the awards on the grant date. That cost is recognized over the period during which an employee is required to provide service in exchange for the award. Stock compensation for stock granted to non-employees is determined as the fair value of the consideration received or the fair value of equity instruments issued, whichever is more reliably measured.
	Net Loss per Common Share
	Basic loss per share is computed by dividing loss available to common stockholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include additional common shares available upon exercise of stock options and warrants using the treasury stock method, except for periods for which no common share equivalents are included because their effect would be anti-dilutive. At December 31, 2014 and 2013, potentially dilutive shares outstanding amounted to 1,208,089 and 1,109,724, respectively.
	Reclassifications
	Certain prior period financial statement amounts have been reclassified to conform to current period presentation.
	Recently Issued Accounting Pronouncements
	In June 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 2014-10 which eliminated in its entirety the differential reporting requirements applicable to development stage entities under ASC 915, Development Stage Entities. Thus, the distinction between development stage entities and other types of reporting entities will no longer exist, and all differential reporting requirements applicable to development stage entities were removed from United States generally accepted accounting principles. Specifically, the amendments eliminated the requirements for development stage entities to (1) present inception-to-date information in the income statement, cash flows statement, and statement of stockholders' equity, (2) identify the financial statements as those of a development stage entity, (3) provide a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity becomes an operating company that it had previously been in the development stage. Adoption of ASC 2014-10 is required for annual reporting periods beginning after December 15, 2014 with early application permitted. The Company has elected early application of this standard.
	Management does not believe that any other recently issued, but not yet effective standards, if adopted, will have a material effect on the financial statements.
	Emerging Growth Company
	The Company is an emerging growth company as defined under the Jumpstart Our Business Startups Act of 2012 (JOBS Act). An emerging growth company may delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company will remain an emerging growth company until December 31, 2017, although it will lose that status sooner if its revenues exceed $1 billion, if it issues more than $1 billion in non-convertible debt in a three year period, or if the market value of its common stock that is held by non-affiliates exceeds $700 million as of any June 30. At June 30, 2014, the market value of the Company’s common stock held by non-affiliates totaled $71 million.

Fixed_Assets

Fixed Assets	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 3 – Fixed Assets
	Fixed assets are summarized as follows:
		December 31,
		2014		2013
	Machinery and equipment	$	646,000	$	633,000
	Office furniture and equipment		98,000		95,000
	Leasehold improvements		124,000		62,000
	Accumulated depreciation		-605,000		-366,000
			263,000		424,000
	Construction in progress		-		3,000
		$	263,000	$	427,000

Patents_and_Other_Intangible_A

Patents and Other Intangible Assets	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure [Text Block]	Note 4 – Patents and Other Intangible Assets
	Patents and other intangible assets are summarized as follows:
		December 31,
		2014		2013
	Patents
	Patents pending	$	2,262,000	$	1,444,000
	Issued patents		67,000		-
			2,329,000		1,444,000
	Trademarks		36,000		7,000
	Other		8,000		8,000
			2,373,000		1,459,000
	Accumulated amortization		-1,000		-
		$	2,372,000	$	1,459,000
	Future amortization expense associated with awarded patents as of December 31, 2014 is estimated as follows:
	2015	$	7,000
	2016		7,000
	2017		7,000
	2018		7,000
	2019		7,000
	Thereafter		31,000
			66,000
	During the years ended December 31, 2014 and 2013, the Company recorded an impairment loss of $262,000 and $4,000, respectively, from abandonment of capitalized patents pending.

Termination_of_Employment_Agre

Termination of Employment Agreement	12 Months Ended
	Dec. 31, 2014
Employment Agreement Termination [Abstract]
Termination of Employment Agreement Disclosure [Text Block]	Note 5 – Termination of Employment Agreement
	The Company and its former Chief Executive Officer, Richard F. Rutkowski, entered into an agreement in December 2014 terminating a prior employment agreement. Under this agreement, Mr. Rutkowski will be paid his annual salary of $359,000 through December 31, 2016 as well as a bonus of $60,000 in 2015, provided employee benefits through December 2015, and received accelerated vesting on 15,625 stock options with an exercise price of $4.88 per share and 14,219 stock options with an exercise price of $9.90 per share which terminate in March 2015.
	The following weighted-average assumptions were utilized in the calculation of the fair value of the modified stock options:
	Expected life	0.25 years
	Weighted average volatility	68	%
	Forfeiture rate	46	%
	Weighted average risk-free interest rate	0.04	%
	Expected dividend rate	-
	The liability incurred under this agreement totaled $943,000 which was recognized in general and administrative expense in 2014 and included the $50,000 fair value of the stock option provisions. At December 31, 2014, the remaining liability totaled $842,000 with $470,000 due in 2015 and $372,000 due in 2016.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Note 6 - Income Taxes
	Through December 31, 2014, the Company incurred net operating losses for federal tax purposes of approximately $20,100,000. The net operating loss carry forward may be used to reduce taxable income through the years 2028 to 2034. The availability of the Company's net operating loss carry forward is subject to limitation if there is a 50% or more change in the ownership of the Company's stock.
	A reconciliation of the expected tax computed at the statutory federal income tax rate to the provision for income taxes is as follows:
		2014		2013
	Expected tax benefit at 34%	$	-2,481,000	$	-1,797,000
	Change in valuation allowance		2,390,000		1,615,000
	Other		91,000		182,000
	Provision for income taxes	$	-	$	-
	The net deferred tax asset at December 31, 2014 and 2013 was $7,080,000 and $4,690,000, respectively. A 100% valuation allowance has been established against the deferred tax assets as the utilization of the loss carry forward cannot reasonably be assured. Significant components of the deferred tax assets (liabilities), computed at the statutory federal tax rate of 34%, are approximately as follows:
		2014		2013
	Net operating loss carry forwards	$	6,850,000	$	4,780,000
	Accrued liabilities		310,000		30,000
	Stock compensation		-20,000		-30,000
	Depreciation		-40,000		-80,000
	Prepaid expenses		-30,000		-20,000
	Other		10,000		10,000
	Deferred tax assets, net		7,080,000		4,690,000
	Valuation allowance		-7,080,000		-4,690,000
	Net deferred tax asset	$	-	$	-
	Although the Company is not under examination, the tax years for 2011 and forward are subject to examination by United States tax authorities. The Company’s practice is to recognize interest and penalties related to income tax matters in income tax expense. As of December 31, 2014 and 2013, there was no accrued interest or penalties related to uncertain tax positions.

Stockholders_Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Note 7 – Stockholders’ Equity
	Common Stock and Preferred Stock
	The Company is authorized to issue 62,500,000 shares of common stock and 2,000,000 shares of preferred stock. Preferences, limitations, voting powers and relative rights of any preferred stock to be issued may be determined by the Company’s Board of Directors. The Company has not issued any shares of preferred stock.
	In March 2014, the Company completed a registered direct offering of common stock whereby 812,500 shares were issued at $8.00 per share. Gross proceeds from the offering totaled $6.5 million and net cash proceeds approximated $5.8 million. Expenses of the offering approximated $0.8 million. Cash expenses included placement agent fees of $488,000, placement agent legal and other fees of $75,000, issuer legal fees of $113,000, and other costs of $44,000. Non-cash expenses consisted of a warrant to purchase 20,313 shares of the Company’s common stock at $10.00 per share exercisable until March 2019 valued at $92,000.
	As described in Note 11, the Company completed a $17.5 million underwritten public offering of common stock in February 2015.
	Equity Incentive Plan
	The Company has an Equity Incentive Plan (the Plan) which provides for the granting of options to purchase shares of common stock, stock awards to purchase shares at no less than 85% of the value of the shares, and stock bonuses to officers, employees, board members, certain consultants, and advisors. The Compensation Committee of the Board of Directors is authorized to administer the Plan and establish the grant terms, including the grant price, vesting period and exercise date. As of December 31, 2014, the number of shares reserved for issuance under the Equity Incentive Plan totaled 1,077,005 shares. The Plan provides for quarterly increases in the available number of authorized shares equal to the lesser of 10% of any new shares issued by the Company during the quarter immediately prior to the adjustment date or such lesser amount as the Board of Directors shall determine.  Activity under the Plan is as follows:
			2014		2013
	Reserved but unissued shares under the Equity Incentive Plan, beginning of year			249,736		480,260
	Increases in the number of authorized shares under the Equity Incentive Plan			85,705		5,866
	Grants of stock options			-141,880		-206,390
	Stock option forfeitures			24,688		-
	Exercise of stock options			39,140		-
	Stock grants			-14,625		-30,000
	Stock grant forfeitures			-		-
	Reserved but unissued shares under the Equity Incentive Plan, end of year			242,764		249,736
	Stock Options
	In 2014, the Company granted 122,880 and 19,000 stock options, respectively, under the Plan to certain employees and consultants. The stock options have exercise prices of $9.90 and $8.22 per share, the grant date fair values, a contractual life of 10 years, and vest over four years. As permitted by SAB 107, due to the Company’s insufficient history of option activity, management utilized the simplified approach to estimate the options’ expected term, which represents the period of time that options granted are expected to be outstanding. Expected volatility was determined through the Company’s historical stock price volatility. The Company estimated the forfeiture rate at the time of grant and will revise it, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company recognizes compensation costs only for those equity awards expected to vest. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield in effect at the time of grant. The Company has never declared or paid dividends and has no plans to do so in the foreseeable future. The following weighted-average assumptions were utilized in the calculation of the fair value of the stock options:
	Expected life		6.25 years
	Weighted average volatility		74	%
	Forfeiture rate		13	%
	Weighted average risk-free interest rate		1.93	%
	Expected dividend rate		-
	The fair value of stock options granted estimated on the date of grant using the Black-Scholes option valuation model was $799,000. The recognized compensation expense associated with these grants in 2014 was $178,000.
	In 2013, the Company granted 203,990 and 2,400 stock options, respectively, under the Plan to certain employees. The stock options have exercise prices of $4.88 and $7.33 per share, the grant date fair values, a contractual life of 10 years, and vest over four years. The following weighted-average assumptions were utilized in the calculation of the fair value of the stock options:
	Expected life		6.25 years
	Weighted average volatility		33	%
	Forfeiture rate		13	%
	Weighted average risk-free interest rate		1.31	%
	Expected dividend rate		-
	The fair value of stock options granted estimated on the date of grant using the Black-Scholes option valuation model was $307,000. The recognized compensation expense associated with these grants in 2014 and 2013 was $122,000 and $76,000, respectively.
	A summary of the Company’s stock option activity and related information is as follows:
			2014						2013
							Weighted						Weighted
			Options				Average		Options				Average
			to		Weighted		Remaining		To		Weighted		Remaining
			Purchase		Average		Contractual		Purchase		Average		Contractual
			Common		Exercise		Life		Common		Exercise		Life
			Stock		Price		(in years)		Stock		Price		(in years)
	Outstanding at January 1			565,765	$	3.19		8.21		359,375	$	2.2		8.75
	Granted			141,880	$	9.68		7.7		206,390	$	4.91		9.01
	Exercised			-39,140	$	3.11		-		-		-		-
	Forfeited/Expired/Exchanged			-24,688	$	7.36		-		-		-		-
	Outstanding at December 31			643,817	$	4.46		5.67		565,765	$	3.19		8.21
	Exercisable at December 31			441,958	$	3.5		4.47		317,354	$	2.44		7.87
	In accordance with the Plan, 7,504 stock options were exercised in 2014 prior to vesting and the resulting shares of common stock were issued with a declining repurchase right in favor of the Company at the exercise price of $4.88 per share should the employee terminate employment or upon other related circumstances prior to December 31, 2016. At December 31, 2014, all 7,504 shares remained subject to this repurchase right.
	A summary of the status of the Company’s non-vested stock options at December 31 and changes during the year is as follows:
			2014				2013
					Weighted				Weighted
			Number of		Average Grant		Number of		Average Grant
			Options		Date Fair Value		Options		Date Fair Value
	Non-vested stock options at January 1			248,411	$	4.15		117,188	$	2.2
	Granted			141,880	$	9.68		206,390	$	4.91
	Vested			-156,240	$	5.5		-75,167	$	3.21
	Exercised			-7,504	$	4.88		-		-
	Forfeited/Expired/Exchanged			-24,688	$	7.36		-		-
	Non-vested stock options at December 31			201,859	$	6.57		248,411	$	4.15
	The estimated aggregate pretax intrinsic value of the Company’s outstanding vested stock options at December 31, 2014 is $1,788,000. The intrinsic value is the difference between the Company’s common stock price and the option exercise prices multiplied by the number of in-the-money options. This amount changes based on the fair value of the Company’s common stock.
	At December 31, 2014, there was $601,000 of total unrecognized compensation cost related to non-vested stock option-based compensation arrangements granted under the Plan. That cost is expected to be recognized in future years as follows:
	2015		$	229,000
	2016			209,000
	2017			153,000
	2018			10,000
			$	601,000
The recognized compensation cost associated with the Plan is as follows:
		2014		2013
Research and development		$	99,000	$	42,000
General and administrative			240,000		73,000
Effect on net loss		$	339,000	$	115,000
Effect on net loss per share		$	0.04	$	0.01
Stock Grants
In 2014 and 2013, the Company granted 14,625 and 30,000 shares, respectively, of common stock under the Equity Incentive Plan to its three independent directors in accordance with agreements for service on the board. The fair value of the stock at the time of grant was $10.26 and $5.00 per share for a total value of $150,000 in 2014 and 2013, respectively, which the Company recognized in general and administrative expense.
In 2011, the Company granted 125,000 shares of stock under the Equity Incentive Plan to a key employee which are subject to declining repurchase rights by the Company at $0.0001 per share should the employee terminate employment or upon other related circumstances prior to September 30, 2016. The Company recognized general and administrative compensation expense of $26,000 and $31,000 in 2014 and 2013, respectively. The remaining cost is reflected as a contra-equity balance against additional paid in capital and is expected to be recognized in future years as follows:
2015		$	26,000
2016			20,000
		$	46,000
Consultant Stock Plan
In May 2013, the shareholders approved the 2013 Consultant Stock Plan (the Consultant Plan) which provides for the granting of shares of common stock to consultants who provide services related to capital raising, investor relations, and making a market in or promoting the Company’s securities. The Company’s officers, employees, and board members are not entitled to receive grants from the Consultant Plan. The Compensation Committee of the Board of Directors is authorized to administer the Consultant Plan and establish the grant terms. The number of shares reserved for issuance under the Consultant Plan on the date of adoption in May 2013 totaled 75,000 shares and on December 31, 2014 totaled 83,858 shares. The Consultant Plan provides for quarterly increases in the available number of authorized shares equal to the lesser of 1% of any new shares issued by the Company during the quarter immediately prior to the adjustment date or such lesser amount as the Board of Directors shall determine.
The Company granted 7,000 and 11,250 shares from the Consultant Plan to a consultant for services in 2014 and 2013, respectively. The fair value of the stock at the time of grant was $10.26 and $9.12 per share for a total value of $72,000 in 2014 and $102,000 in 2013 which the Company recognized in general and administrative expense.
Activity under the Consultant Plan from its inception to date is as follows:
		2014		2013
Reserved but unissued shares under the Consultant Plan			64,037		75,000
Increases in the number of authorized shares under the Consultant Plan			8,571		287
Stock grants			-7,000		-11,250
Stock grant forfeitures			-		-
Reserved but unissued shares under the Consultant Plan			65,608		64,037
Warrants
In conjunction with the March 2014 registered direct offering of common stock, the Company granted a warrant to the placement agent to purchase 20,313 common stock shares at $10.00 per share exercisable until March 2019. The fair value of these warrants was estimated to be $92,000 on the date of the grant using the Black-Scholes option-pricing model. Expected volatility was determined based upon the historical prices of the Company’s common stock. The risk-free rate for periods within the contractual life of the warrants is based on the U.S. Treasury yield in effect at the time of grant. The Company has never declared or paid dividends and has no plans to do so in the foreseeable future. The following weighted-average assumptions were utilized for the calculations:
Expected life (in years)		5
Weighted average volatility		74	%
Weighted average risk-free interest rate		1.49	%
Expected dividend rate		-
In 2013, a warrant to purchase 17,409 shares of common stock at $2.20 per share was exercised whereby the Company received $39,000 in proceeds. A summary of the Company’s warrant activity and related information is as follows:
		2014				2013
				Weighted Average				Weighted Average
		Warrants		Exercise Price		Warrants		Exercise Price
Outstanding at beginning of year			543,959	$	3.92		561,368	$	3.86
Granted			20,313	$	10		-		-
Exercised			-		-		-17,409	$	2.2
Forfeited/Expired			-		-		-		-
Outstanding at end of year			564,272	$	4.14		543,959	$	3.92
The following table summarizes the number of warrants, the weighted average exercise price, and weighted average life (in years) by price for both total outstanding warrants and total exercisable warrants at December 31, 2014:
			Total Outstanding Warrants
Exercise Price			Warrants	Weighted Average			Life
				Exercise Price			(in years)
$	1.8		80,000	$	1.8		6.13
$	2.2		118,959	$	2.2		1.36
$	5		345,000	$	5		2.32
$	10		20,313	$	10		4.18
			564,272	$	4.14

Retirement_Plan

Retirement Plan	12 Months Ended
	Dec. 31, 2014
Retirement Plan [Abstract]
Retirement Plan [Text Block]	Note 8 – Retirement Plan
	The Company has a defined contribution retirement plan covering all of its employees whereby the Company matches employee contributions up to 3% of each employee’s 2014 and 2013 earnings. The Company’s matching contribution expense totaled $53,000 and $38,000 in 2014 and 2013, respectively.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 9 – Related Party Transactions
	In 2013, the Company incurred consulting fees of $103,000 to the Alternative Energy Resource Alliance, a non-profit organization whose executive director is David Goodson. In exchange, Mr. Goodson provided scientific consulting services to the Company. Mr. Goodson is a director and co-founder of the Company and, through an irrevocable trust, a significant beneficial owner of the Company's common stock at December 31, 2014.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 10 – Commitments and Contingencies
	On February 3, 2015, the Company and its newly-appointed Chief Executive Officer, Stephen E. Pirnat entered into an employment agreement (the Agreement) which terminates on December 31, 2017, unless earlier terminated. Compensation under the Agreement includes an annual salary of $350,000 with annual cost-of-living adjustments, a grant of stock options as described in Note 11, annual cash bonuses that may equal up to 60% of his annual salary and equity bonuses based on performance standards established by the Compensation Committee of the Board of Directors, medical and dental benefits for Mr. Pirnat and his family, and relocation expenses up to approximately $100,000. The Agreement may be terminated by the Company without cause under certain circumstances, as defined in the Agreement whereby a severance payment would be due in the amount of compensation that would have been due had employment not been terminated or one year of the current annual compensation, whichever is greater. In the event of a change in control, Mr. Pirnat would receive one year’s compensation and all previously granted stock options would vest in full.
	The Company has agreements with its three independent directors to compensate them annually. The obligation totals $300,000 per year of which $150,000 is to be paid with the Company’s common stock at fair value. Directors are elected annually.
	The Company has a triple net lease for office and laboratory space through February 2017. Under the terms of the lease, the Company paid no rent for the period November 2011 to February 2012 and for February 2014. Rent escalates annually by 3%. The Company records monthly rent expense equal to the total of the payments over the lease term divided by the number of months of the lease term. Therefore, rent expense of $2,000 was accrued in 2014. In 2013, the deferred rent was reduced by $4,000. Under the terms of the lease, the Company will also pay monthly triple net operating costs which currently approximate $3,000 per month. Minimum future payments under this lease at December 31, 2014 are as follows:
	2015	$	137,000
	2016		141,000
	2017		24,000
		$	302,000
	For the years ended December 31, 2014 and 2013, rent expense amounted to $161,000 and $135,000, respectively.
	The Company has a Field Test Agreement with Southern California-based Aera Energy LLC to demonstrate and test the Duplex technology in a once through steam generator (OTSG) used to facilitate the production of heavy oil in California’s San Joaquin Valley. Under the terms of the agreement, the Company has retrofit an OTSG unit in order to achieve certain performance criteria. Assuming successful completion of the demonstration and testing, the agreement also includes time-sensitive pricing, delivery and installation terms, if elected, that will apply to future purchases by Aera Energy LLC of this Duplex application.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 11 – Subsequent Events
	In February 2015, the Company completed an underwritten public offering of common stock whereby 2,990,000 shares were issued at $5.85 per share. Gross proceeds from the offering totaled $17.5 million and net cash proceeds approximated $16.3 million. Expenses of the offering approximated $1.2 million, including underwriting fees of $1,050,000, underwriter legal fees and other costs of $55,000, and other costs of $110,000. The offering was underwritten by MDB Capital Group, LLC, a significant beneficial owner of the Company's common stock at December 31, 2014.
	In February 2015, the Company and its Chief Executive Officer, Stephen E. Pirnat, entered into an employment agreement as described in Note 10. In accordance with the employment agreement, the Company immediately granted to Mr. Pirnat 100,000 stock options under the Equity Incentive Plan. The stock options have an exercise price of $5.97 per share, the grant date fair value, vest on February 3, 2016, and have a contractual life of 10 years. The fair value of stock options estimated on the date of grant using the Black-Scholes option valuation model was $334,000. Further, effective April 1, 2015, the Company will issue to Mr. Pirnat an option to purchase 200,000 shares of common stock with an exercise price equal to the fair value of the common stock on April 1, 2015. The option will vest 50% on April 1, 2016 and 50% on April 1, 2017, and will have a contractual life of 10 years.
	In February 2015, the Company authorized 23,034 shares of common stock to be issued under the Equity Incentive Plan to its three independent directors in accordance with board agreements and which will be earned quarterly for service in 2015. The fair value of the stock at the time of grant was $5.97 per share for a total value of $138,000 which the Company will recognize in general and administrative expense on a pro-rated quarterly basis in 2015.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Use Of Estimates, Policy [Policy Text Block]	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition
	The Company recognizes revenue on co-development agreements using the percentage of completion method. Under this method, the completion percentage is determined by dividing costs incurred to date by total estimated project costs. Since these projects will require technological development to complete, which by its nature is difficult to predict, the actual cost required to complete contracted work may vary from estimates. Estimated project costs are revised regularly which can alter the reported level of project profitability. Any estimated project losses are recognized in the current reporting period. Customer billings are recorded when cash receipts are probable and in accordance with the underlying co-development contract. If billings exceed recognized revenue, the difference is recorded as a current liability, while any recognized revenues exceeding billings are recorded as a current asset. Recognized revenues are subject to revisions as the contract progresses to completion and actual revenue and cost become certain. Revisions in revenue estimates are reflected in the period in which the facts that give rise to the revision become known. There were no revenues for the year ended December 31, 2014 and $93,000 for the year ended December 31, 2013.
Cost of Sales, Policy [Policy Text Block]	Cost of Revenue
	Cost of co-development revenue includes both direct and allocated indirect costs of completing the scope of work of co-development agreements. Direct costs include labor, materials and other costs incurred directly in fulfilling co-development agreements. Indirect costs include labor, rent, depreciation and other costs associated with operating the Company. Due to the nature of the work involved, the cost of co-development projects may fluctuate substantially from period to period.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents
	Highly liquid investments purchased with an original maturity of three months or less are considered cash equivalents. Cash is maintained with a commercial bank where accounts are generally guaranteed by the Federal Deposit Insurance Corporation up to $250,000. The Company’s deposits may at times exceed this limit. The Company has not experienced losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.
Fixed Assets Policy [Policy Text Block]	Fixed Assets
	Fixed assets are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Leasehold improvements are depreciated over the life of the lease or their useful life, whichever is shorter. All other fixed assets are depreciated over two to four years. Maintenance and repairs are expensed as incurred.
Patents and Trademarks Policy [Policy Text Block]	Patents and Trademarks
	Patents and trademarks are recorded at cost. Amortization is computed using the straight-line method over the estimated useful lives of the assets once they are awarded.
Impairment Of Long Lived Asset Policy [Policy Text Block]	Impairment of Long-Lived Assets
	The Company tests long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected to result from the use and eventual disposition of the assets. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal.
Fair Value Of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments
	Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
	The Company's financial instruments primarily consist of cash and cash equivalents, accounts payable and accrued expenses. As of the balance sheet dates, the estimated fair values of the financial instruments were not materially different from their carrying values as presented on the balance sheets. This is primarily attributed to the short maturities of these instruments. The Company did not identify any other non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value.
Research and Development Expense, Policy [Policy Text Block]	Research and Development
	The cost of research and development is expensed as incurred. Research and development costs consist of salaries, benefits, share based compensation, consulting fees, rent, utilities, depreciation, and consumables. In 2014, the Company received $110,000 to partially fund certain laboratory research activities. Since these funds were provided without expectation of reciprocation except notification of the research results, the Company recognized these funds when they were received and recorded them as an offset to research and development expense.
Deferred Rent Policy [Policy Text Block]	Deferred Rent
	Operating lease agreements which contain provisions for future rent increases or periods in which rent payments are reduced or abated are recorded in monthly rent expense in the amount of the total payments over the lease term divided by the number of months of the lease term. The difference between rent expense recorded and the amount paid is credited or charged to deferred rent which is reflected on the accompanying balance sheets.
Income Tax, Policy [Policy Text Block]	Income Taxes
	The Company accounts for income taxes using an asset and liability approach which allows for the recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. Tax benefits from an uncertain tax position are recognized only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate resolution.
Share-Based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation
	The costs of all employee stock options, as well as other equity-based compensation arrangements, are reflected in the financial statements based on the estimated fair value of the awards on the grant date. That cost is recognized over the period during which an employee is required to provide service in exchange for the award. Stock compensation for stock granted to non-employees is determined as the fair value of the consideration received or the fair value of equity instruments issued, whichever is more reliably measured.
Earnings Per Share, Policy [Policy Text Block]	Net Loss per Common Share
	Basic loss per share is computed by dividing loss available to common stockholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include additional common shares available upon exercise of stock options and warrants using the treasury stock method, except for periods for which no common share equivalents are included because their effect would be anti-dilutive. At December 31, 2014 and 2013, potentially dilutive shares outstanding amounted to 1,208,089 and 1,109,724, respectively.
Reclassification, Policy [Policy Text Block]	Reclassifications
	Certain prior period financial statement amounts have been reclassified to conform to current period presentation.
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Pronouncements
	In June 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 2014-10 which eliminated in its entirety the differential reporting requirements applicable to development stage entities under ASC 915, Development Stage Entities. Thus, the distinction between development stage entities and other types of reporting entities will no longer exist, and all differential reporting requirements applicable to development stage entities were removed from United States generally accepted accounting principles. Specifically, the amendments eliminated the requirements for development stage entities to (1) present inception-to-date information in the income statement, cash flows statement, and statement of stockholders' equity, (2) identify the financial statements as those of a development stage entity, (3) provide a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity becomes an operating company that it had previously been in the development stage. Adoption of ASC 2014-10 is required for annual reporting periods beginning after December 15, 2014 with early application permitted. The Company has elected early application of this standard.
	Management does not believe that any other recently issued, but not yet effective standards, if adopted, will have a material effect on the financial statements.
Growing Company [Policy Text Block]	Emerging Growth Company
	The Company is an emerging growth company as defined under the Jumpstart Our Business Startups Act of 2012 (JOBS Act). An emerging growth company may delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company will remain an emerging growth company until December 31, 2017, although it will lose that status sooner if its revenues exceed $1 billion, if it issues more than $1 billion in non-convertible debt in a three year period, or if the market value of its common stock that is held by non-affiliates exceeds $700 million as of any June 30. At June 30, 2014, the market value of the Company’s common stock held by non-affiliates totaled $71 million.

Fixed_Assets_Tables

Fixed Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Fixed assets are summarized as follows:
		December 31,
		2014		2013
	Machinery and equipment	$	646,000	$	633,000
	Office furniture and equipment		98,000		95,000
	Leasehold improvements		124,000		62,000
	Accumulated depreciation		-605,000		-366,000
			263,000		424,000
	Construction in progress		-		3,000
		$	263,000	$	427,000

Patents_and_Other_Intangible_A1

Patents and Other Intangible Assets(Tables)	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill [Table Text Block]	Patents and other intangible assets are summarized as follows:
		December 31,
		2014		2013
	Patents
	Patents pending	$	2,262,000	$	1,444,000
	Issued patents		67,000		-
			2,329,000		1,444,000
	Trademarks		36,000		7,000
	Other		8,000		8,000
			2,373,000		1,459,000
	Accumulated amortization		-1,000		-
		$	2,372,000	$	1,459,000
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Future amortization expense associated with awarded patents as of December 31, 2014 is estimated as follows:
	2015	$	7,000
	2016		7,000
	2017		7,000
	2018		7,000
	2019		7,000
	Thereafter		31,000
			66,000

Termination_of_Employment_Agre1

Termination of Employment Agreement (Tables)	12 Months Ended
	Dec. 31, 2014
Employment Agreement Termination [Abstract]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	The following weighted-average assumptions were utilized in the calculation of the fair value of the modified stock options:
	Expected life	0.25 years
	Weighted average volatility	68	%
	Forfeiture rate	46	%
	Weighted average risk-free interest rate	0.04	%
	Expected dividend rate	-

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	A reconciliation of the expected tax computed at the statutory federal income tax rate to the provision for income taxes is as follows:
		2014		2013
	Expected tax benefit at 34%	$	-2,481,000	$	-1,797,000
	Change in valuation allowance		2,390,000		1,615,000
	Other		91,000		182,000
	Provision for income taxes	$	-	$	-
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	A 100% valuation allowance has been established against the deferred tax assets as the utilization of the loss carry forward cannot reasonably be assured. Significant components of the deferred tax assets (liabilities), computed at the statutory federal tax rate of 34%, are approximately as follows:
		2014		2013
	Net operating loss carry forwards	$	6,850,000	$	4,780,000
	Accrued liabilities		310,000		30,000
	Stock compensation		-20,000		-30,000
	Depreciation		-40,000		-80,000
	Prepaid expenses		-30,000		-20,000
	Other		10,000		10,000
	Deferred tax assets, net		7,080,000		4,690,000
	Valuation allowance		-7,080,000		-4,690,000
	Net deferred tax asset	$	-	$	-

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2014
Schedule of Share-based Compensation, Activity [Table Text Block]	A summary of the status of the Company’s non-vested stock options at December 31 and changes during the year is as follows:
			2014				2013
					Weighted				Weighted
			Number of		Average Grant		Number of		Average Grant
			Options		Date Fair Value		Options		Date Fair Value
	Non-vested stock options at January 1			248,411	$	4.15		117,188	$	2.2
	Granted			141,880	$	9.68		206,390	$	4.91
	Vested			-156,240	$	5.5		-75,167	$	3.21
	Exercised			-7,504	$	4.88		-		-
	Forfeited/Expired/Exchanged			-24,688	$	7.36		-		-
	Non-vested stock options at December 31			201,859	$	6.57		248,411	$	4.15
Schedule Of Recognized Compensation Cost [Table Text Block]	The recognized compensation cost associated with the Plan is as follows:
			2014		2013
	Research and development		$	99,000	$	42,000
	General and administrative			240,000		73,000
	Effect on net loss		$	339,000	$	115,000
	Effect on net loss per share		$	0.04	$	0.01
Schedule Of Expected Recognition Of General And Administrative Expense [Table Text Block]	The remaining cost is reflected as a contra-equity balance against additional paid in capital and is expected to be recognized in future years as follows:
	2015		$	26,000
	2016			20,000
			$	46,000
Schedule Of Share Based Payment Award Warrants Valuation Assumptions [Table Text Block]	The following weighted-average assumptions were utilized for the calculations:
	Expected life (in years)		5
	Weighted average volatility		74	%
	Weighted average risk-free interest rate		1.49	%
	Expected dividend rate		-
Schedule Of Share Based Compensation Warrants Activity [Table Text Block]	The following table summarizes the number of warrants, the weighted average exercise price, and weighted average life (in years) by price for both total outstanding warrants and total exercisable warrants at December 31, 2014:
				Total Outstanding Warrants
	Exercise Price			Warrants	Weighted Average			Life
					Exercise Price			(in years)
	$	1.8		80,000	$	1.8		6.13
	$	2.2		118,959	$	2.2		1.36
	$	5		345,000	$	5		2.32
	$	10		20,313	$	10		4.18
				564,272	$	4.14
Equity Incentive Plan [Member]
Schedule of Share-based Compensation, Activity [Table Text Block]	Activity under the Plan is as follows:
			2014		2013
	Reserved but unissued shares under the Equity Incentive Plan, beginning of year			249,736		480,260
	Increases in the number of authorized shares under the Equity Incentive Plan			85,705		5,866
	Grants of stock options			-141,880		-206,390
	Stock option forfeitures			24,688		-
	Exercise of stock options			39,140		-
	Stock grants			-14,625		-30,000
	Stock grant forfeitures			-		-
	Reserved but unissued shares under the Equity Incentive Plan, end of year			242,764		249,736
Consultant Plan [Member]
Schedule of Share-based Compensation, Activity [Table Text Block]	Activity under the Consultant Plan from its inception to date is as follows:
			2014		2013
	Reserved but unissued shares under the Consultant Plan			64,037		75,000
	Increases in the number of authorized shares under the Consultant Plan			8,571		287
	Stock grants			-7,000		-11,250
	Stock grant forfeitures			-		-
	Reserved but unissued shares under the Consultant Plan			65,608		64,037
Warrant [Member]
Schedule Of Share Based Compensation Warrants Activity [Table Text Block]	A summary of the Company’s warrant activity and related information is as follows:
			2014				2013
					Weighted Average				Weighted Average
			Warrants		Exercise Price		Warrants		Exercise Price
	Outstanding at beginning of year			543,959	$	3.92		561,368	$	3.86
	Granted			20,313	$	10		-		-
	Exercised			-		-		-17,409	$	2.2
	Forfeited/Expired			-		-		-		-
	Outstanding at end of year			564,272	$	4.14		543,959	$	3.92
Employee Stock Option [Member]
Schedule Of Share Based Payment Award Warrants Valuation Assumptions [Table Text Block]	The following weighted-average assumptions were utilized in the calculation of the fair value of the stock options:
	Expected life		6.25 years
	Weighted average volatility		74	%
	Forfeiture rate		13	%
	Weighted average risk-free interest rate		1.93	%
	Expected dividend rate		-
	The following weighted-average assumptions were utilized in the calculation of the fair value of the stock options:
	Expected life		6.25 years
	Weighted average volatility		33	%
	Forfeiture rate		13	%
	Weighted average risk-free interest rate		1.31	%
	Expected dividend rate		-
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	A summary of the Company’s stock option activity and related information is as follows:
			2014						2013
							Weighted						Weighted
				Options			Average			Options			Average
				to	Weighted		Remaining			To	Weighted		Remaining
				Purchase	Average		Contractual			Purchase	Average		Contractual
			Common		Exercise		Life		Common		Exercise		Life
			Stock		Price		(in years)		Stock		Price		(in years)
	Outstanding at January 1			565,765	$	3.19		8.21		359,375	$	2.2		8.75
	Granted			141,880	$	9.68		7.7		206,390	$	4.91		9.01
	Exercised			-39,140	$	3.11		-		-		-		-
	Forfeited/Expired/Exchanged			-24,688	$	7.36		-		-		-		-
	Outstanding at December 31			643,817	$	4.46		5.67		565,765	$	3.19		8.21
	Exercisable at December 31			441,958	$	3.5		4.47		317,354	$	2.44		7.87
Schedule Of Employee Service Share Based Compensation Unrecognized Period Costs [Table Text Block]	At December 31, 2014, there was $601,000 of total unrecognized compensation cost related to non-vested stock option-based compensation arrangements granted under the Plan. That cost is expected to be recognized in future years as follows:
	2015		$	229,000
	2016			209,000
	2017			153,000
	2018			10,000
			$	601,000

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Minimum future payments under this lease at December 31, 2014 are as follows:
	2015	$	137,000
	2016		141,000
	2017		24,000
		$	302,000

Organization_and_Description_o1

Organization and Description of Business (Details Textual) (USD $)	12 Months Ended		83 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014
Organization and Description of Business [Line Items]
Net loss	$7,296,000	$5,285,000	$21,260,000

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details Textual) (USD $)	1 Months Ended	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Jun. 30, 2014
Variable Interest Entity [Line Items]
Cash, FDIC Insured Amount	$250,000	$250,000
Weighted Average Number of Shares Outstanding, Diluted		1,208,089	1,109,724
Emerging Growth Company Minimum Revenue		1,000,000,000
Emerging Growth Company Non Convertible Debt	1,000,000,000	1,000,000,000
Emerging Growth Company Minimum Non-Affiliate Market Value Of Common Stock				700,000,000
Tax Benefits Recognized Description		The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate resolution.
Emerging Growth Company Non-Affiliate Market Value Of Common Stock				71,000,000
Technology Services Revenue		0	93,000
Proceeds From Fund To Offset Research And Development	$110,000

Fixed_Assets_Details

Fixed Assets (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Machinery and equipment	$646,000	$633,000
Office furniture and equipment	98,000	95,000
Leasehold improvements	124,000	62,000
Accumulated depreciation	-605,000	-366,000
Property Plant and Equipment Gross Excluding Construction In Progress	263,000	424,000
Construction in progress	0	3,000
Property, Plant and Equipment, Net, Total	$263,000	$427,000

Patents_and_Other_Intangible_A2

Patents and Other Intangible Assets (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Patents, Gross	$2,329,000	$1,444,000
Trademarks	36,000	7,000
Other	8,000	8,000
Finite-Lived Intangible Assets, Gross	2,373,000	1,459,000
Accumulated amortization	-1,000	0
Finite-Lived Intangible Assets, Net	2,372,000	1,459,000
Patents Pending [Member]
Finite-Lived Patents, Gross	2,262,000	1,444,000
Issued Patents [Member]
Finite-Lived Patents, Gross	67,000	0
Finite-Lived Intangible Assets, Net	$66,000

Patents_and_Other_Intangible_A3

Patents and Other Intangible Assets (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net	$2,372,000	$1,459,000
Issued Patents [Member]
Finite-Lived Intangible Assets [Line Items]
2015	7,000
2016	7,000
2017	7,000
2018	7,000
2019	7,000
Thereafter	31,000
Finite-Lived Intangible Assets, Net	$66,000

Patents_and_Other_Intangible_A4

Patents and Other Intangible Assets (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Exploration Abandonment and Impairment Expense	$262,000	$4,000

Termination_of_Employment_Agre2

Termination of Employment Agreement (Details)	12 Months Ended
	Dec. 31, 2014
Expected life	3 months
Weighted average volatility	68.00%
Forfeiture rate	46.00%
Weighted average risk-free interest rate	0.04%
Expected dividend rate	0.00%

Termination_of_Employment_Agre3

Termination of Employment Agreement (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2016	Dec. 31, 2015
Loss Contingency Accrual, Provision	$50,000
Richard F. Rutkowski [Member] | Option One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares	15,625
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value	$4.88
Richard F. Rutkowski [Member] | Option Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares	14,219
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value	$9.90
Scenario, Forecast [Member]
Financial Liabilities Fair Value Disclosure	842,000	372,000	470,000
Scenario, Forecast [Member] | Richard F. Rutkowski [Member]
Officers' Compensation		359,000	60,000
General and Administrative Expense [Member]
Financial Liabilities Fair Value Disclosure	$943,000

Income_Taxes_Details

Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Tax Reconciliation [Line Items]
Expected tax benefit at 34%	($2,481,000)	($1,797,000)
Change in valuation allowance	2,390,000	1,615,000
Other	91,000	182,000
Provision for income taxes	$0	$0

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Income Tax Reconciliation [Line Items]
Net operating loss carry forwards	$6,850,000	$4,780,000
Accrued liabilities	310,000	30,000
Stock compensation	-20,000	-30,000
Depreciation	-40,000	-80,000
Prepaid expenses	-30,000	-20,000
Other	10,000	10,000
Deferred tax assets, net	7,080,000	4,690,000
Valuation allowance	-7,080,000	-4,690,000
Net deferred tax asset	$0	$0

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Tax Contingency [Line Items]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%
Limitation In Carry Forward Percentage Of Net Operating Loss	50.00%
Percentage Of Valuation Allowance Against Deferred Tax Assets	100.00%
Net Operating Losses For Tax Purposes	$20,100,000
Operating Loss Carryforward Expiration Date	The net operating loss carry forward may be used to reduce taxable income through the years 2028 to 2034.
Deferred Tax Assets, Net of Valuation Allowance	$0	$0

Stockholders_Equity_Details

Stockholders' Equity (Details) (Equity Incentive Plan [Member])	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Equity Incentive Plan [Member]
Class of Stock [Line Items]
Reserved but unissued shares under the Plan	249,736	480,260
Increases in the number of authorized shares under the Plan	85,705	5,866
Grants of stock options	-141,880	-206,390
Stock option forfeitures	24,688	0
Exercise of stock options	39,140	0
Stock grants	-14,625	-30,000
Stock grant forfeitures	0	0
Reserved but unissued shares under the Plan	242,764	249,736

Stockholders_Equity_Details_1

Stockholders' Equity (Details 1) (Employee Stock Option [Member])	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life	6 years 3 months	6 years 3 months
Weighted average volatility	74.00%	33.00%
Forfeiture rate	13.00%	13.00%
Weighted average risk-free interest rate	1.93%	1.31%
Expected dividend rate	0.00%	0.00%

Stockholders_Equity_Details_2

Stockholders' Equity (Details 2) (Employee Stock Option [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Employee Stock Option [Member]
Class of Stock [Line Items]
Reserved but unissued shares under the Plan	565,765	359,375
Granted - Options to Purchase Common Stock	141,880	206,390
Exercised - Options to Purchase Common Stock	-39,140	0
Forfeited/Expired/Exchanged - Options to Purchase Common Stock	-24,688	0
Reserved but unissued shares under the Plan	643,817	565,765	359,375
Exercisable - Options to Purchase Common Stock	441,958	317,354
Outstanding - Weighted Average Exercise Price	$3.19	$2.20
Granted - Weighted Average Exercise Price	$9.68	$4.91
Exercised - Weighted Average Exercise Price	$3.11	$0
Forfeited/Expired/Exchanged - Weighted Average Exercise Price	$7.36	$0
Outstanding - Weighted Average Exercise Price	$4.46	$3.19	$2.20
Exercisable - Weighted Average Exercise Price	$3.50	$2.44
Outstanding - Weighted Average Remaining Contractual Life (in years)	5 years 8 months 1 day	8 years 2 months 16 days	8 years 9 months
Granted - Weighted Average Remaining Contractual Life (in years)	7 years 8 months 12 days	9 years 4 days
Exercised - Weighted Average Remaining Contractual Life (in years)	0 years	0 years
Forfeited/Expired/Exchanged - Weighted Average Remaining Contractual Life (in years)	0 years	0 years
Exercisable - Weighted Average Remaining Contractual Life (in years)	4 years 5 months 19 days	7 years 10 months 13 days

Stockholders_Equity_Details_3

Stockholders' Equity (Details 3) (Employee Stock Option [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Employee Stock Option [Member]
Class of Stock [Line Items]
Non-vested stock options at January 1	248,411	117,188
Granted - Number of Options	141,880	206,390
Vested - Number of Options	-156,240	-75,167
Exercised - Number of Options	-7,504	0
Forfeited/Expired/Exchanged - Number of Options	-24,688	0
Non-vested stock options at December 31	201,859	248,411
Non-vested options - Weighted Average Grant Date Fair Value	$4.15	$2.20
Granted - Weighted Average Grant Date Fair Value	$9.68	$4.91
Vested - Weighted Average Grant Date Fair Value	$5.50	$3.21
Exercised - Weighted Average Grant Date Fair Value	$4.88	$0
Forfeited/Expired/Exchanged - Weighted Average Grant Date Fair Value	$7.36	$0
Non-vested options - Weighted Average Grant Date Fair Value	$6.57	$4.15

Stockholders_Equity_Details_4

Stockholders' Equity (Details 4) (USD $)	Dec. 31, 2014
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	$601,000
Year 2015 [Member]
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	229,000
Year 2016 [Member]
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	209,000
Year 2017 [Member]
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	153,000
Year 2018 [Member]
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	$10,000

Stockholders_Equity_Details_5

Stockholders' Equity (Details 5) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Effect on net loss	$339,000	$115,000
Effect on net loss per share (in dollars per share)	$0.04	$0.01
Research and development [Member]
Effect on net loss	99,000	42,000
General and administrative [Member]
Effect on net loss	$240,000	$73,000

Stockholders_Equity_Details_6

Stockholders' Equity (Details 6) (USD $)	12 Months Ended
	Dec. 31, 2014
Other General and Administrative Expense	$46,000
Year 2015 [Member]
Other General and Administrative Expense	26,000
Year 2016 [Member]
Other General and Administrative Expense	$20,000

Stockholders_Equity_Details_7

Stockholders' Equity (Details 7) (Consultant Plan [Member])	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Consultant Plan [Member]
Reserved but unissued shares under the Plan	64,037	75,000
Increases in the number of authorized shares under the Plan	8,571	287
Stock grants	-7,000	-11,250
Stock grant forfeitures	0	0
Reserved but unissued shares under the Plan	65,608	64,037

Stockholders_Equity_Details_8

Stockholders' Equity (Details 8) (Warrant [Member])	12 Months Ended
	Dec. 31, 2014
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life (in years)	5 years
Weighted average volatility	74.00%
Weighted average risk-free interest rate	1.49%
Expected dividend rate	0.00%

Stockholders_Equity_Details_9

Stockholders' Equity (Details 9) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Warrant [Member]
Outstanding - Warrants	543,959	561,368
Granted - Warrants	20,313	0
Exercised - Warrants	0	-17,409
Forfeited/Expired - Warrants	0	0
Outstanding - Warrants	564,272	543,959
Outstanding - Weighted Average Exercise Price at beginning of year	$3.92	$3.86
Granted - Weighted Average Exercise Price	$10	$0
Exercised - Weighted Average Exercise Price	$0	$2.20
Forfeited/Expired - Weighted Average Exercise Price	$0	$0
Outstanding - Weighted Average Exercise Price at end of year	$4.14	$3.92

Stockholders_Equity_Details_10

Stockholders' Equity (Details 10) (USD $)	12 Months Ended
	Dec. 31, 2014
Warrants Outstanding	564,272
Warrants Outstanding Weighted Average Exercise Price	$4.14
Exercise Price 1.80 [Member]
Warrants Exercise Price	$1.80
Warrants Outstanding	80,000
Warrants Outstanding Weighted Average Exercise Price	$1.80
Warrants Outstanding Remaining Life	6 years 1 month 17 days
Exercise Price 2.20 [Member]
Warrants Exercise Price	$2.20
Warrants Outstanding	118,959
Warrants Outstanding Weighted Average Exercise Price	$2.20
Warrants Outstanding Remaining Life	1 year 4 months 10 days
Exercise Price 5.00 [Member]
Warrants Exercise Price	$5
Warrants Outstanding	345,000
Warrants Outstanding Weighted Average Exercise Price	$5
Warrants Outstanding Remaining Life	2 years 3 months 25 days
Exercise Price 10.00 [Member]
Warrants Exercise Price	$10
Warrants Outstanding	20,313
Warrants Outstanding Weighted Average Exercise Price	$10
Warrants Outstanding Remaining Life	4 years 2 months 5 days

Stockholders_Equity_Details_Te

Stockholders' Equity (Details Textual) (USD $)	3 Months Ended	12 Months Ended			1 Months Ended
	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2011	Feb. 26, 2015	Mar. 31, 2014	31-May-13	Dec. 31, 2012
Class of Stock [Line Items]
Warrants Authorized For Issuance To Acquire Common Stock Shares Number	20,313	20,313
Exercise Price Of Warrants	$10
Warrants Authorized For Issuance To Acquire Common Stock Value	$92,000	$92,000
Stock Issued During Period, Value, Issued for Noncash Considerations				125,000
Common Stock, Shares Authorized		62,500,000
Preferred Stock, Shares Authorized		2,000,000
Declining Repurchase Rights Per Share				$0.00
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized		601,000
Stock Issued In Registered Direct Offering Price Per Share		$8
Stock Granted During Period, Value, Share-Based Compensation, Gross		26,000	31,000
Stock Issued During Period Value Exercise Of Warrant			39,000
Proceeds From Issuance Or Sale Of Equity		5,780,000	39,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value		1,788,000
Registered Direct Offering [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, New Issues	6,500,000
Stock Issued In Registered Direct Offering Price Per Share	$8
Placement Agent Fees	488,000
Payments for Placement Agent Legal Fees	75,000
Other Cost and Expense, Operating	44,000
Stock Issued During Period, Shares, Registered Direct Offering	812,500
Proceeds From Issuance Or Sale Of Equity	5,800,000
Payment of Financing and Stock Issuance Costs	800,000
Subsequent Event [Member] | Underwritten Public Offering [Member]
Class of Stock [Line Items]
Gross Proceeds From Public Stock Offering Of Common Stock					17,500,000
Employee Stock Option [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		4 years	4 years
Consultant Plan [Member]
Class of Stock [Line Items]
Share-based Compensation Outstanding - Reserved but unissued shares under the Plan		83,858					75,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		7,000	11,250
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		$10.26	$9.12
Stock Granted During Period, Value, Share-Based Compensation, Gross		72,000	102,000
Common Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period Value Exercise Of Warrant			0
Stock Issued During Period, Shares, Registered Direct Offering		812,500
Warrant [Member]
Class of Stock [Line Items]
Warrants Authorized For Issuance To Acquire Common Stock Shares Number						20,313
Exercise Price Of Warrants						$10
Warrants Authorized For Issuance To Acquire Common Stock Value						92,000
Equity Incentive Plan [Member]
Class of Stock [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Purchase Price Share Minimum		85.00%
Common Stock, Capital Shares Reserved for Future Issuance		1,077,005
Increase Decrease Of Share Based Compensation Arrangement By Share Based Payment Award Percentage		10.00%
Share-based Compensation Outstanding - Reserved but unissued shares under the Plan		242,764	249,736					480,260
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		141,880	206,390
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		$10.26	$5
Stock Granted During Period, Value, Share-Based Compensation, Gross		150,000	150,000
Share Based Compensation Arrangement By Share Based Payment Award Stock Grants In Period		-14,625	-30,000
Equity Incentive Plan [Member] | Employee Stock Option [Member]
Class of Stock [Line Items]
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized		601,000
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Subject To Repurchase Rights Decline		7,504
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term		10 years	10 years
Stock Granted During Period, Value, Share-Based Compensation, Gross		799,000	307,000
Investment Options, Exercise Price		$4.88
Allocated Share-based Compensation Expense		178,000	76,000
Equity Incentive Plan [Member] | Employee Stock Option One [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		122,880	203,990
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		$9.90	$4.88
Equity Incentive Plan [Member] | Employee Stock Option Two [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		19,000	2,400
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		$8.22	$7.33
Legal Fees [Member] | Registered Direct Offering [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Issued for Noncash Considerations	$113,000

Retirement_Plan_Details_Textua

Retirement Plan (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Retirement Plan [Line Items]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	3.00%	3.00%
Defined Contribution Plan, Cost Recognized	$53,000	$38,000

Related_Party_Transactions_Det

Related Party Transactions (Details Textual) (Alternative Energy Resource Alliance [Member], USD $)	12 Months Ended
	Dec. 31, 2013
Alternative Energy Resource Alliance [Member]
Related Party Transaction [Line Items]
Consulting Fee	$103,000

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	Dec. 31, 2014
Operating Leased Assets [Line Items]
2015	$137,000
2016	141,000
2017	24,000
Operating Leases, Future Minimum Payments Due	$302,000

Commitments_and_Contingencies_2

Commitments and Contingencies (Details Textual) (USD $)	12 Months Ended		0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Feb. 03, 2015
Loss Contingencies [Line Items]
Rent Expense Escalation Percentage	3.00%
Increase In Deferred Rent	$2,000
Reduction In Deferred Rent		4,000
Operating Leases, Rent Expense	161,000	135,000
Contractual Obligation	300,000
Obligation To Pay In Common Stock At Fair Value	150,000
Triple Net Operating Cost	3,000
Stephen E. Pirnat [Member]
Loss Contingencies [Line Items]
Salaries, Wages and Officers' Compensation			350,000
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate			60.00%
Labor and Related Expense			$100,000

Subsequent_Events_Details_Text

Subsequent Events (Details Textual) (Subsequent Event [Member], USD $)	0 Months Ended	1 Months Ended
	Feb. 03, 2015	Feb. 26, 2015	Apr. 30, 2015
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value		$5.97
Share Based Compensation Arrangement by Share Based Payment Award Options Grants In Period Fair Value		$138,000
Payments of Stock Issuance Costs	1,200,000
Underwriting Fees [Member]
Subsequent Event [Line Items]
Payments of Stock Issuance Costs		1,050,000
Other Costs [Member]
Subsequent Event [Line Items]
Payments of Stock Issuance Costs		110,000
Legal Fees [Member]
Subsequent Event [Line Items]
Payments of Stock Issuance Costs		55,000
Three Independent Directors [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		23,034
Stephen E. Pirnat [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		100,000	200,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value		$5.97
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date		3-Feb-16
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		10 years
Share Based Compensation Arrangement by Share Based Payment Award Options Grants In Period Fair Value		334,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights		The stock options will have an exercise price of the grant date fair value, will vest 50% on April 1, 2016 and 50% on April 1, 2017, and will have a contractual life of 10 years.
Underwritten Public Offering [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues		2,990,000
Stock Issued During Period Value Per Share		$5.85
Gross Proceeds From Public Stock Offering Of Common Stock		17,500,000
Net Proceeds From Public Stock Offering Of Common Stock		$16,300,000